Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ESPR

Esperion

$40.40

1.39 (3.56%)

16:41
03/23/17
03/23
16:41
03/23/17
16:41
Hot Stocks
Breaking Hot Stocks news story on Esperion »

Boxer Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Wednesday
ESPR

Esperion

$39.05

-2.17 (-5.26%)

06:34
03/22/17
03/22
06:34
03/22/17
06:34
Recommendations
Esperion analyst commentary at Citi »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Tuesday
ESPR

Esperion

$41.22

17.55 (74.14%)

05:56
03/21/17
03/21
05:56
03/21/17
05:56
Recommendations
Esperion analyst commentary at JPMorgan »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Monday
ESPR

Esperion

$41.22

17.55 (74.14%)

, CALA

Calithera Biosciences

$12.35

-0.05 (-0.40%)

17:33
03/20/17
03/20
17:33
03/20/17
17:33
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Esperion (ESPR),…

ESPR

Esperion

$41.22

17.55 (74.14%)

CALA

Calithera Biosciences

$12.35

-0.05 (-0.40%)

OCUL

Ocular Therapeutix

$9.87

0.37 (3.89%)

LJPC

La Jolla

$38.44

2.56 (7.13%)

MMSI

Merit Medical

$31.55

0.2 (0.64%)

GBDC

Golub Capital

$19.42

0.02 (0.10%)

GEL

Genesis Energy

$31.60

-0.88 (-2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 28

    Mar

  • 19

    Jul

  • 21

    Mar

  • 23

    Mar

ESPR

Esperion

$23.67

-5.98 (-20.17%)

14:27
03/20/17
03/20
14:27
03/20/17
14:27
Recommendations
Esperion analyst commentary at JMP Securities »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

ESPR

Esperion

$23.67

-5.98 (-20.17%)

, AMGN

Amgen

$168.61

-11.5 (-6.39%)

13:58
03/20/17
03/20
13:58
03/20/17
13:58
Hot Stocks
Esperion jumps as FDA clears approval path for cholesterol drug »

Shares of Esperion…

ESPR

Esperion

$23.67

-5.98 (-20.17%)

AMGN

Amgen

$168.61

-11.5 (-6.39%)

MDCO

The Medicines Co.

$48.38

-4.2 (-7.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 28

    Mar

  • 19

    Jul

ESPR

Esperion

$23.67

-5.98 (-20.17%)

, AMGN

Amgen

$168.61

-11.5 (-6.39%)

11:10
03/20/17
03/20
11:10
03/20/17
11:10
Recommendations
Esperion, Amgen analyst commentary at JPMorgan »

Esperion LDL-C lowering…

ESPR

Esperion

$23.67

-5.98 (-20.17%)

AMGN

Amgen

$168.61

-11.5 (-6.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 28

    Mar

  • 19

    Jul

ESPR

Esperion

$23.67

-5.98 (-20.17%)

10:42
03/20/17
03/20
10:42
03/20/17
10:42
Periodicals
TheStreet's Feuerstein calls Esperion rally 'puzzling' »

TheStreet's Adam…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

ESPR

Esperion

$23.67

-5.98 (-20.17%)

10:01
03/20/17
03/20
10:01
03/20/17
10:01
Recommendations
Esperion analyst commentary at Citi »

Esperion likely needs to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

ESPR

Esperion

$23.67

-5.98 (-20.17%)

09:49
03/20/17
03/20
09:49
03/20/17
09:49
Upgrade
Esperion rating change at Credit Suisse »

Esperion upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.